Sculptra

DEVICE3 trials

Sponsors

Galderma R&D, Massachusetts General Hospital

Conditions

Gene ExpressionMidface Volume DeficitSkin Aging

Phase 4

Randomized Trial of Combination Treatment With Sofwave and Sculptra

Not yet recruitingNCT07342452

Massachusetts General HospitalSkin Aging

Start: 2026-04-01End: 2027-04-01Target: 13Updated: 2026-01-15

Unknown Phase

Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

CompletedNCT04132518

Galderma R&DMidface Volume Deficit

Start: 2019-11-12End: 2022-07-18Updated: 2025-01-07

Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler

CompletedNCT05620043

Galderma R&DGene Expression

Start: 2022-09-28End: 2023-11-06Updated: 2024-03-22